Clioquinol
Cat.No:IC4250 Solarbio
CAS:130-26-7
Molecular Formula:C9H5ClINO
Molecular Weight:305.5
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
{{cart_num}}
My CartCAS:130-26-7
Molecular Formula:C9H5ClINO
Molecular Weight:305.5
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
CAS | 130-26-7 |
Name | Clioquinol |
Molecular Formula | C9H5ClINO |
Molecular Weight | 305.5 |
Solubility | Soluble in DMSO ≥5mg/mL |
Purity | ≥98% |
Appearance | Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 204-984-4 |
MDL | MFCD00006787 |
SMILES | C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1 |
InChIKey | QCDFBFJGMNKBDO-UHFFFAOYSA-N |
InChI | InChI=1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H |
PubChem CID | 2788 |
Target Point | Fungal |
Passage | Anti-infection |
Background | It is an oily, copper - bound halogenated 8-hydroxyquinoline (8-hydroxyquinoline) with antifungal activity. |
Biological Activity | Clioquinol 是一种具有口服活性的、亲油性的、铜离子结合的卤代8-羟基喹啉(8-hydroxyquinoline),具有抗真菌、抗寄生物以及潜在的抗肿瘤活性。[1-2] |
Data Literature Source | [1]. Pollera C,et al. Evaluation of anti-prionic activity of clioquinol in an in vivo model (Mesocricetus auratus). Vet Res Commun. 2005 Aug;29 Suppl 2: 253-5. [2]. Yu H,et al. Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J. 2009 Jan 1;417(1): 133-9. |
Unit | Bottle |
Specification | 500mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.